Mizuho Securities Starts Eli Lilly (LLY) at Neutral

Mizuho Securities analyst Vamil Divan initiates coverage on Eli Lilly (NYSE: LLY) with a Neutral rating and a price target of $148.00.

The analyst comments "Trulicity and Taltz are key drivers of Lilly's top and bottom-line growth but we expect Verzenio’s impact to increase following recent positive data releases and see the Loxo acquisition providing additional mid-term growth drivers. We are also supportive of the management team and appreciate the steps they have already taken to generate shareholder value, while we expect their productivity to continue to increase as Lilly transitions to focusing more on specialty markets. However, incorporating all of those positives into our model still leads us to a valuation close to the current stock price and keeps us on the sidelines."

For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.

Shares of Eli Lilly closed at $143.44 yesterday.

You May Also Be Interested In

• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)